How much debt does Haemonetics have?

Haemonetics had total debt of $1.22B as of Mar 31, 2026, against $245.44M in cash and short-term investments. Its debt-to-equity ratio was 1.54. Total debt was $1.22B a year earlier.

What are Haemonetics's total assets?

Haemonetics reported total assets of $2.40B as of Mar 31, 2026, down 2.2% from $2.45B a year earlier. Total liabilities were $1.60B.

What is Haemonetics's shareholders' equity?

Haemonetics's shareholders' equity was $796.32M as of Mar 31, 2026, or about $17.60 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry.

Haemonetics (HAE) Balance Sheet: Assets & Liabilities

Haemonetics Balance Sheet Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Haemonetics Corporation (HAE) - Annual data in billions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Mar 2025	Mar 2024	Apr 2023	Mar 2023	Apr 2022	Mar 2022	Apr 2021	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Current Assets
Cash and Cash Equivalents	0.25	0.31	0.18	0.28	0.28	0.26	0.26	0.19	0.19	0.14	0.17	0.18	0.14
Cash & Short-Term Investments	0.25	0.31	0.18	0.29	0.28	0.26	0.26	0.19	0.19	0.14	0.17	0.18	0.14
Accounts Receivable	0.22	0.20	0.21	0.18	0.18	0.16	0.16	0.13	0.13	0.17	0.19	0.15	0.15
Inventory	0.31	0.37	0.32	0.26	0.26	0.29	0.29	0.32	0.32	0.27	0.19	0.16	0.18
Other Current Assets	0.07	0.06	0.07	0.05	0.05	0.04	0.04	0.05	0.05	0.03	0.05	0.06	0.08
Total Current Assets	0.83	0.93	0.77	0.77	0.77	0.76	0.76	0.69	0.69	0.60	0.58	0.52	0.51
Non-Current Assets
Property, Plant & Equipment (Net)	0.31	0.28	0.37	0.31	0.31	0.26	0.26	0.22	0.22	0.25	0.34	0.33	0.32
Long-Term Investments	0.00	0.00	0.00	-	0.00	-	0.00	-	0.00	0.00	0.00	0.00	0.00
Goodwill	0.66	0.60	0.57	0.47	0.47	0.47	0.47	0.47	0.47	0.21	0.21	0.21	0.21
Intangible Assets	0.45	0.46	0.41	0.28	0.28	0.31	0.31	0.37	0.37	0.13	0.13	0.16	0.18
Other Non-Current Assets	0.14	0.16	0.08	0.11	0.11	0.07	0.06	0.08	0.07	0.06	0.02	0.02	0.02
Total Non-Current Assets	1.56	1.52	1.43	-	1.17	-	1.10	-	1.13	0.66	0.70	0.72	0.73
Total Assets	2.40	2.45	2.20	1.93	1.93	1.86	1.86	1.82	1.82	1.27	1.27	1.24	1.24
Current Liabilities
Accounts Payable	0.05	0.07	0.07	0.06	0.06	0.06	0.06	0.05	0.05	0.05	0.06	0.06	0.04
Short-Term Debt	0.01	0.30	0.01	0.01	0.01	0.21	0.22	0.02	0.02	0.08	0.03	0.19	0.06
Current Portion of Long-Term Debt	-	0.30	0.01	0.01	-	0.22	-	0.02	-	-	-	-	-
Accrued Liabilities	0.07	0.06	0.08	0.06	0.06	0.05	0.05	0.05	-	-	-	-	-
Deferred Revenue	0.04	0.04	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03
Other Current Liabilities	0.12	0.16	0.19	0.11	0.08	0.12	0.12	0.14	0.13	0.09	0.11	0.10	0.07
Total Current Liabilities	0.28	0.58	0.30	0.25	0.25	0.44	0.44	0.25	0.25	0.27	0.24	0.38	0.21
Non-Current Liabilities
Long-Term Debt	1.22	0.92	0.80	0.75	0.75	0.56	0.56	0.69	0.75	0.36	0.32	0.06	0.25
Deferred Tax Liabilities	0.04	0.06	0.06	0.04	0.04	0.03	0.03	0.04	0.04	0.01	0.02	0.01	0.01
Other Non-Current Liabilities	0.06	0.07	0.08	0.11	0.07	0.11	0.08	0.14	0.04	0.03	0.03	0.03	0.02
Total Non-Current Liabilities	1.32	1.05	0.94	0.87	0.87	0.67	0.67	0.83	0.83	0.41	0.37	0.10	0.29
Total Liabilities	1.60	1.63	1.24	1.12	1.12	1.11	1.11	1.09	1.09	0.68	0.61	0.48	0.50
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	0.28	0.35	0.36	0.25	0.25	0.20	0.20	0.16	0.16	0.08	0.16	0.27	0.29
Accumulated Other Comprehensive Income	-0.04	-0.06	-0.04	-0.03	-0.03	-0.03	-0.03	-0.03	-0.03	-0.05	-0.03	-0.02	-0.03
Additional Paid-in Capital	0.55	0.52	0.63	-	0.59	-	0.57	-	0.60	0.55	0.54	0.50	0.48
Shares Outstanding	0.05	0.05	0.05	-	0.05	-	0.05	-	-	-	-	-	-
Total Stockholders' Equity	0.80	0.82	0.96	0.82	0.82	0.75	0.75	0.73	0.73	0.59	0.67	0.75	0.74
Total Liabilities & Equity	2.40	2.45	2.20	-	1.93	-	1.86	-	1.82	1.27	1.27	1.24	1.24

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Haemonetics Balance Sheet Analysis

Frequently Asked Questions About Haemonetics Balance Sheet